Background: The Saudi population has experienced a sharp increase in colorectal and gastric cancer incidences within the last few years. The relationship between gene polymorphisms of xenobiotic metabolizing enzymes and colorectal cancer (CRC) incidence has not previously investigated among the Saudi population. The aim of the present study was to investigate contributions of CYP1A1, CYP2E1, and GSTM1 gene polymorphisms. Materials and Methods: Blood samples were collected from CRC patients and healthy controls and genotypes were determined by polymerase chain reaction restriction fragment length polymorphism and sequencing. Results and Conclusions: considered polymorphisms. Investigation of genetic risk factors and susceptibility gene polymorphisms in our Saudi population should be helpful for better understanding of CRC etiology.
Introduction
Colorectal cancer (CRC) is one of the most frequent causes of cancer death in industrialized countries with a yearly incidence of 50 new cases for every 100,000 people in the population (Boyle and Ferlay, 2005) . CRC is the third most common cancer in the world and its prevalence has been steadily increasing over the last century, while mortality rates have declined as a result of improved et al., 2004; Parkin et al., 2005) . CRC is traditionally and represents a complex disease which development is mediated by genetic and environmental factors (Potter, reported the association between polymorphisms for gene encoding enzymes involved in biotransformation of xenobiotics and susceptibility to cancers (Induski and Lutz, 2000; Chang et al., 2003; Terry et al., 2003) . The human body is exposed daily to a number of xenobiotics including drugs, dietary compounds and environmental carcinogens which are metabolized by a variety of enzymes through phase I and phase II reactions (Bozina et al., 2009 ). These enzymes participate in the conversion of xenobiotics to more water soluble metabolites which are readily excreted from the body. During metabolism of some of these xenobiotics a variety of unstable and reactive intermediates can be formed which could attack et al., 2009). The key enzyme system involved in such activation process are phase I xenobiotic metabolizing enzymes (XMEs) such as cytochrome P450s (CYPs) xenobiotics, including environmental carcinogens, chemotherapeutic agents and reactive oxygen species (Taspinar et al., 2008) . Mutations in the genes that code for these enzymes can affect the metabolism of chemical carcinogens and which alters susceptibility to different important for the conversion of carcinogenic polycyclic long arm of chromosome 15q22-qter (Corchero et after exposure to inducer than the non exposed group (Kellerman et al., 1973) . In genotyping studies, two been well studied in Caucasian and Oriental populations, increased sensitivity to inducer in some studies and the exon 7 Ile-Val substitution that appears to result in higher higher rates of carcinogen activation than individuals with the wild-type allele. The CYP2E1 enzyme, a member of the cytochrome P450 superfamily, is a natural ethanolinducible enzyme that is involved in the metabolic oxidation of low molecular weight carcinogens such as N-nitrosoamines, benzene and vinyl chloride (Liu et al., 2009 (Chang and Yang, 2000) .
cancer incidence has not been investigated previously. The aim of the present study was to test for potential
Materials and Methods
This study was conducted after review and approval of the Institutional Review Board of the Ethics Committee cancer patients (65 males and 27 females, age range, 26-80 years; mean age, 58.4 years) and 79 healthy controls matched for age and sex. The control samples were collected from subjects referred to the hospital for general medical checkups. Colon cancer tissue samples were also collected from 12 unrelated colorectal cancer patients 8 males and 4 females and histologically normal tissues in the distant margin to the tumour were collected at the time of surgery from the patient who undergoing resection of colorectal tumours. The diagnosis of cancer was based on standard clinical, endoscopic, radiological, and histological criteria. Clinical and demographic characteristics were recorded, including age at diagnosis, gender, family history, smoking habits, disease behaviour, disease location, and need for surgery. Tissue samples to were homogenized in RLT lyses buffer (Qiagen Co., instructions. Elution was performed with 50 µl nucleasefree water. Concentration, purity, and quality of the according to instruction provided by the manufacturer Integrity Numbers, RIN were ranged from 6.4-8.6 in CRC by reverse transcription and used as a template for expression levels. 10X and 40X. Five images of representative areas were acquired for each specimen.
equilibrium (http://ihg2.helmholtz-muenchen.de/cgi-bin/ hw/hwa1.pl). Case-control and other genetic comparisons were performed using the chi-square test and allelic odds
Results
It should be noted that the molecular tools used for the genotyping do not determine whether other polymorphisms in the same gene are also present in the tested subject. The wild type (wt) denotation thus refers to the wild type allele at the investigated polymorphic site only, regardless of other unstudied polymorphisms for that particular gene. Furthermore, in this study, there were no for the three investigated genes when male groups were compared with females groups (data not shown).
tested subjects and statistical analysis of the obtained data are detailed in Figure 3B ). On the other hand, detectable levels of under investigation ( Figure 3B ).
T h e r e l i a b i l i t y o f t h e e x p r e s s i o n q P C R immunohistochemistry on colon cancer tumour samples be highly expressed in colon cancer tissues as indicated by strong staining ( Figure 4C ) when compared with control tissues (polyp) (weak staining) ( Figure 4B ). Overtumour progression indicating a potential role in tumour development. expected to exhibit high rates of carcinogen activation (Lindi et al., 1994) . The present study showed that the CRC compared to control normal tissues as measured by with normal tissues. This finding was confirmed by immunohistochemistry study using anti-cytochrome P450 than normal adjacent control tissues. Many studies have investigated the relationship between CYP2E1 gene variation and the risk of CRC. The indicated that the polymorphism caused by the presence or absence of a DraI site in CYP2E1 intron 6 has no This is in agreement with a previous study about CRC in a Taiwanese population (Dil LIio et al., 1987) and Lebanese population (Darazy et al., 2011) . The effect of this mutation on CYP2E1 enzyme activity is still not well established; however, an increased risk for CRC was detected among Italian population ever drinkers carrying frequency of this allele and the low number of samples in term of association might be due to a difference in the frequency of this polymorphism among these populations as well as to other factors related to the diet and the environment. In addition, the presence of other genetic might also affect the strength of the association. For of chemical carcinogens, also exhibits a gene deletion associated with a 1.91-fold increase in the risk of CRC, but genotypes was associated with an even higher OR of 4.98
Discussion
In conclusion, the work undertaken in this study raises a number of interesting observations. First, the factors in the analyzed population. Third, all genes under investigation were found to be highly expressed in CRC patients which is likely to be an important determinant in predicting the outcome of cancer chemotherapy. Finally, large-scale studies with more CRC patients are required to draw a clearer picture about the genetic factors of CRC
